Asset Management Corp’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$1.31M Sell
5,611
-1,143
-17% -$289K 1.03% 21
2022
Q4
$1.7M Hold
6,754
1.43% 17
2022
Q3
$1.2M Sell
6,754
-51
-0.7% -$10.2K 0.72% 32
2022
Q2
$1.24M Sell
6,805
-293
-4% -$58.4K 0.8% 30
2022
Q1
$1.82M Buy
7,098
+398
+6% +$91K 0.91% 27
2021
Q4
$1.54M Hold
6,700
0.76% 32
2021
Q3
$1.56M Hold
6,700
0.78% 28
2021
Q2
$1.29M Hold
6,700
0.74% 34
2021
Q1
$1.39K Sell
6,700
-500
-7% -$106K 0.59% 36
2020
Q4
$1.51M Hold
7,200
0.84% 30
2020
Q3
$929K Hold
7,200
0.56% 39
2020
Q2
$627K Hold
7,200
0.4% 55
2020
Q1
$434K Hold
7,200
0.39% 66
2019
Q4
$534K Buy
+7,200
New +$463K 0.38% 73

Other funds holding INSP

Asset Management Corp's INSP Position: Q1 2023 in Review

Asset Management Corp reduced its Inspire Medical Systems (INSP) stake by 17% in Q1 2023, selling an estimated $289K and leaving 5,611 shares worth $1.31M. The position accounts for 1.03% of the portfolio, ranked #21.

Asset Management Corp first reported a position in INSP in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.82M in Q1 2022. 373 funds tracked by Wall St. Rank hold INSP as of Q1 2023.

  • Asset Management Corp held 5,611 shares of Inspire Medical Systems worth $1.31M as of Q1 2023.
  • Asset Management Corp sold 1,143 Inspire Medical Systems shares in Q1 2023, an estimated $289K.
  • Inspire Medical Systems made up 1.03% of Asset Management Corp's portfolio in Q1 2023, its #21 holding.
  • Asset Management Corp first reported a position in Inspire Medical Systems in Q4 2019 and has held it in 14 quarters since.
  • Asset Management Corp's Inspire Medical Systems position peaked at $1.82M in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.